Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Information on the total number of voting rights and shares
By: GlobenewsWire - 30 Sep 2022Back to overview list

REGULATED INFORMATION

Mont-Saint-Guibert (Belgium), September 30, 2022, 10:30 pm CET / 4:30 pm ET – In accordance with article  15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the belowinformation following the issue of new shares.

  •  Share capital: EUR 4,440,069.16 
  •  Total number of securities carrying voting rights: 25,846,279 (all ordinary shares) 
  •  Total number of voting rights (= denominator): 25,846,279 (all relating to ordinary shares)  
  •  Number of rights to subscribe to securities carrying voting rights not yet issued: 
    •  55 “2016 ESOP Warrants” issued on November 3, 2016, entitling their holders to subscribe to a total number of 27,500 securities carrying voting rights (all ordinary shares); 
    •  100 “2018 ESOP Warrants” issued on December 12, 2018, entitling their holders to subscribe to a total number of 50,000 securities carrying voting rights (all ordinary shares);  
    •  460,500 “2020 ESOP Warrants” issued on February 21, 2020, entitling their holders to subscribe to a total number of 460,500 securities carrying voting rights (all ordinary shares); and
    •  1,378,125 “2021 ESOP Warrants” issued on September 8, 2021, entitling their holders to subscribe to a total number of 1,378,125 securities carrying voting rights (all ordinary shares).  

*

*        *

For further information, please contact:

Nyxoah
Jeremy Feffer, VP IR and Corporate Communications
jeremy.feffer@nyxoah.com

+1 917 749 1494 

Attachment


Related companies:Nyxoah
Copyright 2022 GlobenewsWire Back to overview list
to the top ↑